Airsculpt Technologies Inc (AIRS) - Net Assets
Based on the latest financial reports, Airsculpt Technologies Inc (AIRS) has net assets worth $100.26 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($192.00 Million) and total liabilities ($91.74 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check AIRS tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $100.26 Million |
| % of Total Assets | 52.22% |
| Annual Growth Rate | -5.14% |
| 5-Year Change | 5.01% |
| 10-Year Change | N/A |
| Growth Volatility | 16.89 |
Airsculpt Technologies Inc - Net Assets Trend (2019–2025)
This chart illustrates how Airsculpt Technologies Inc's net assets have evolved over time, based on quarterly financial data. See Airsculpt Technologies Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Airsculpt Technologies Inc (2019–2025)
The table below shows the annual net assets of Airsculpt Technologies Inc from 2019 to 2025. For live valuation and market cap data, see Airsculpt Technologies Inc (AIRS) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $87.71 Million | +10.62% |
| 2024-12-31 | $79.29 Million | -5.60% |
| 2023-12-31 | $83.99 Million | +18.69% |
| 2022-12-31 | $70.77 Million | -15.28% |
| 2021-12-31 | $83.53 Million | -32.46% |
| 2020-12-31 | $123.68 Million | +2.73% |
| 2019-12-31 | $120.39 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Airsculpt Technologies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4057100000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $64.00K | 0.07% |
| Other Comprehensive Income | $-96.00K | -0.11% |
| Other Components | $128.31 Million | 146.29% |
| Total Equity | $87.71 Million | 100.00% |
Airsculpt Technologies Inc Competitors by Market Cap
The table below lists competitors of Airsculpt Technologies Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
VRG SA
WAR:VRG
|
$354.89 Million |
|
NSI NV
AS:NSI
|
$354.91 Million |
|
Universal Vision Biotechnology Co Ltd
TWO:3218
|
$355.02 Million |
|
Good Will Instrument Co Ltd
TW:2423
|
$355.07 Million |
|
Motech Industries Co Ltd
TWO:6244
|
$354.84 Million |
|
Haverty Furniture Companies Inc
NYSE:HVT
|
$354.80 Million |
|
Great Tree Pharmacy Co Ltd
TWO:6469
|
$354.79 Million |
|
Guangdong Anjubao Digital Tech
SHE:300155
|
$354.78 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Airsculpt Technologies Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 79,290,000 to 87,712,000, a change of 8,422,000 (10.6%).
- Net loss of 11,667,000 reduced equity.
- New share issuances of 18,764,000 increased equity.
- Other comprehensive income increased equity by 591,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-11.67 Million | -13.3% |
| Share Issuances | $18.76 Million | +21.39% |
| Other Comprehensive Income | $591.00K | +0.67% |
| Other Changes | $734.00K | +0.84% |
| Total Change | $- | 10.62% |
Book Value vs Market Value Analysis
This analysis compares Airsculpt Technologies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.47x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 2.32x to 3.47x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $2.16 | $5.03 | x |
| 2020-12-31 | $2.22 | $5.03 | x |
| 2021-12-31 | $1.50 | $5.03 | x |
| 2022-12-31 | $1.27 | $5.03 | x |
| 2023-12-31 | $1.48 | $5.03 | x |
| 2024-12-31 | $1.37 | $5.03 | x |
| 2025-12-31 | $1.45 | $5.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Airsculpt Technologies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -13.30%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -7.68%
- • Asset Turnover: 0.81x
- • Equity Multiplier: 2.14x
- Recent ROE (-13.30%) is below the historical average (-4.69%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -1.84% | -5.36% | 0.24x | 1.42x | $-14.25 Million |
| 2020 | 6.13% | 12.07% | 0.35x | 1.45x | $-4.79 Million |
| 2021 | 12.63% | 7.91% | 0.66x | 2.40x | $2.20 Million |
| 2022 | -20.74% | -8.70% | 0.84x | 2.84x | $-21.76 Million |
| 2023 | -5.33% | -2.29% | 0.96x | 2.43x | $-12.88 Million |
| 2024 | -10.41% | -4.57% | 0.86x | 2.65x | $-16.18 Million |
| 2025 | -13.30% | -7.68% | 0.81x | 2.14x | $-20.44 Million |
Industry Comparison
This section compares Airsculpt Technologies Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $481,871,574
- Average return on equity (ROE) among peers: 10114.73%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Airsculpt Technologies Inc (AIRS) | $100.26 Million | -1.84% | 0.91x | $354.84 Million |
| Acadia Healthcare Company Inc (ACHC) | $432.55 Million | 4.72% | 1.27x | $1.52 Billion |
| Addus HomeCare Corporation (ADUS) | $34.58 Million | 11.64% | 2.93x | $1.69 Billion |
| agilon health Inc (AGL) | $661.02 Million | -39.73% | 1.63x | $264.44 Million |
| Amedisys Inc (AMED) | $879.72 Million | 12.80% | 0.48x | $3.32 Billion |
| AMN Healthcare Services Inc (AMN) | $284.13 Million | 12.09% | 1.26x | $624.22 Million |
| American Shared Hospital Service (AMS) | $11.83 Million | 169.54% | 1.28x | $8.87 Million |
| American Oncology Network Inc. (AONC) | $24.17K | 90834.23% | 1.03x | $292.48 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.52 Billion | 13.82% | 2.26x | $1.33 Billion |
| Astrana Health Inc (ASTH) | $510.64 Million | 13.50% | 0.70x | $1.90 Billion |
About Airsculpt Technologies Inc
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also pr… Read more